News & Insights
Stay Informed With Our Latest Updates
Explore our comprehensive collection of news and in-depth insights spanning practice areas, industries, and regions.
Firm News October 9, 2026
Gibson Dunn Represented Veritas Capital and Portfolio Company Finalsite in Acquisition of RevTrak
Gibson Dunn represented Veritas Capital and its portfolio company Finalsite — a leading K–12 platform for school engagement, enrollment, and communications — in the acquisition of RevTrak, a leading digital payments provider serving more than 13,000 schools across the U.S.
Firm News October 9, 2026
Gibson Dunn Advised Aurora Capital Partners on Acquisition of Softdocs
Gibson Dunn advised Aurora Capital Partners on its acquisition of Softdocs, Inc., a proven provider of process automation and document management solutions for education and government institutions.
Firm News October 8, 2026
Gibson Dunn Advised Tower Arch Capital on the Recapitalization of Creedence Energy Services by Monomoy Capital Partners
Gibson Dunn advised Tower Arch Capital, a growth-oriented middle market private equity firm, and its portfolio company, Creedence Energy Services, a leading independent provider of production and midstream chemical solutions that support asset integrity and optimize performance across critical energy infrastructure, on the successful recapitalization of Creedence Energy Services by Monomoy Capital Partners.
Accolades October 2, 2026
Lawdragon Names 29 Gibson Dunn Lawyers to 2027 List of 500 Leading Corporate Employment Lawyers
Lawdragon has named 29 Gibson Dunn lawyers to its 2027 list of 500 Leading Corporate Employment Lawyers – more than any other firm.
Firm News September 24, 2026
Gibson Dunn Wins Dismissal of Antitrust Lawsuit Against Chevron
Gibson Dunn won a dismissal of an antitrust lawsuit filed by Michigan Attorney General Dana Nessel against our client Chevron, along with BP, Exxon, Shell, and the American Petroleum Institute (API).
Accolades September 24, 2026
Gibson Dunn Named One of 2027’s “Fearsome Foursome”
History repeats: Gibson Dunn is yet again part of BTI Consulting Group’s “Fearsome Foursome” — firms that “inspire a different level of dread” when opposing counsel must face them.
In the Media September 23, 2026
Branden Berns and Ryan Murr Discuss Reverse Mergers With Law360 Healthcare Authority
Partners Branden Berns and Ryan Murr were quoted in Law360 Healthcare Authority’s “As Stigma Fades, Reverse Mergers Boom in Biotech.”
Firm News September 17, 2026
Gibson Dunn Advises North Immunology on Merger With Aethlon Medical, Concurrent Private Placement
Gibson Dunn is advising North Immunology, Inc. on its merger with Aethlon Medical, Inc., along with a concurrent private placement expected to fund the combined company's operations into the second half of 2028.
